Format

Send to

Choose Destination
Gynecol Oncol. 2003 Jan;88(1 Pt 2):S152-7.

Current status of the molecular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening.

Author information

1
Cancer Genetics Laboratory, Division of Medical and Molecular Genetics, GKT School of Medicine, Guy's Hospital, London.
PMID:
12586109
DOI:
10.1006/gyno.2002.6708
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center